Effects of the selective dopamine D1 antagonists NNC 01-0112 and SCH 39166 on latent inhibition in the rat
-
Add time:08/28/2019 Source:sciencedirect.com
Dopamine D1 receptor blockade does not appear to be a prerequisite for antipsychotic activity since many clinically effective antipsychotics have little or no affinity for this receptor subtype. Clozapine, however, which has minimal liability for extrapyramidal symptoms, possesses affinities of similar order for D1 and D2 receptors. In earlier animal models used to predict antipsychotic effect, selective D1 antagonists have shown effects similar to standard antipsychotics with preferential D2 or mixed D1/D2 antagonism. We investigated the effects of haloperidol (0.1 mg/kg) and two selective D1 antagonists, NNC 01-0112 (0.05, 0.1 and 0.2 mg/kg) and SCH 39166 (0.02, 0.2 and 2.0 mg/kg), on latent inhibition (LI) in rats. LI is a behavioural paradigm in which repeated nonreinforced preexposure to a stimulus retards subsequent associations to that stimulus. Disrupted LI has been suggested as a model for the attentional deficits in schizophrenia. Using preexposure to a flashing light stimulus, which subsequently served as a conditioned stimulus for suppression of water licking, we demonstrated a clear LI effect with haloperidol but with neither of the two D1 antagonists. Since selective D1 antagonists are not clinically effective, these results add further credibility for the relevance of LI as an animal model of psychosis.
We also recommend Trading Suppliers and Manufacturers of NNC 687 (cas 128022-68-4). Pls Click Website Link as below: cas 128022-68-4 suppliers
Prev:Original article11C- and 76Br-labelled NNC 22-0010, selective dopamine D1 receptor radioligands for PET☆
Next:Effects of chronic discontinuous and continuous treatment of rats with a dopamine D1 receptor antagonist (NNC-756)) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Effects of chronic discontinuous and continuous treatment of rats with a dopamine D1 receptor antagonist (NNC-756)08/29/2019
- Original article11C- and 76Br-labelled NNC 22-0010, selective dopamine D1 receptor radioligands for PET☆08/27/2019
- Original Articles[11C]NNC 22-0215, a Metabolically Stable Dopamine D1 Radioligand for PET08/26/2019
- Dopamine receptor occupancy in vivo: behavioral correlates using NNC-112, NNC-687 and NNC-756, new selective dopamine D1 receptor antagonists08/25/2019
- [11C]NNC 687 (cas 128022-68-4) and [11C]NNC 756, dopamine D-1 receptor ligands. Preparation, autoradiography and PET investigation in monkey08/24/2019
- Selective alterations of the first NREM sleep cycle in humans by a dopamine D1 receptor antagonist (NNC-687)08/23/2019
- NNC-112, NNC-687 and NNC-756, new selective and highly potent dopamine D1 receptor antagonists☆08/22/2019


